|
SUB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.606600E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.818500E-04 |
| Normal-vs-Stage2 |
3.734300E-02 |
| Normal-vs-Stage3 |
1.359820E-01 |
| Normal-vs-Stage4 |
5.770200E-01 |
| Stage1-vs-Stage2 |
9.716000E-01 |
| Stage1-vs-Stage3 |
4.024800E-01 |
| Stage1-vs-Stage4 |
2.970600E-01 |
| Stage2-vs-Stage3 |
4.952000E-01 |
| Stage2-vs-Stage4 |
2.783200E-01 |
| Stage3-vs-Stage4 |
5.778600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.616100E-04 |
| Normal-vs-AfricanAmerican |
7.399900E-02 |
| Normal-vs-Asian |
6.140600E-01 |
| Caucasian-vs-AfricanAmerican |
2.094600E-01 |
| Caucasian-vs-Asian |
4.183000E-01 |
| AfricanAmerican-vs-Asian |
7.174000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.81360000000219E-05 |
| Normal-vs-Female |
3.310400E-01 |
| Male-vs-Female |
1.185960E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.109990E-02 |
| Normal-vs-Extreme_Weight |
3.379900E-03 |
| Normal-vs-Obese |
2.358300E-02 |
| Normal-vs-Extreme_Obese |
1.624430E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.234600E-01 |
| Normal_Weight-vs-Obese |
6.168400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.639400E-01 |
| Extreme_Weight-vs-Obese |
6.332200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.245800E-01 |
| Obese-vs-Extreme_Obese |
1.499580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.350000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.109560E-02 |
| Normal-vs-Age(61-80Yrs) |
6.13529999999862E-05 |
| Normal-vs-Age(81-100Yrs) |
3.297400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.479200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.234840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.019000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.946500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.235600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.514000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.975100E-04 |
| Normal-VS-Type2 PRCC |
3.435600E-04 |
| Normal-VS-KIRP CIMP |
7.884500E-03 |
| Normal-VS-Unclassified PRCC |
1.350800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.927400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.566400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.342400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.797800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.111400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.119200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.559290E-03 |
| Normal-vs-N1 |
6.711800E-01 |
| Normal-vs-N2 |
3.718500E-03 |
| N0-vs-N1 |
6.212200E-02 |
| N0-vs-N2 |
4.044200E-01 |
| N1-vs-N2 |
1.066420E-01 |
|
|
